File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

TitleA phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)
Authors
KeywordsAMG386
Combination therapy
Phase 1
Temsirolimus
Trebananib
Issue Date2016
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
Citation
Investigational New Drugs, 2016, v. 34 n. 1, p. 104-111 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/234690
ISSN
2023 Impact Factor: 3.0
2023 SCImago Journal Rankings: 1.086
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChiu, WYJ-
dc.contributor.authorHotte, SJ-
dc.contributor.authorKollmannsberger, CK-
dc.contributor.authorRenouf, DJ-
dc.contributor.authorCescon, DW-
dc.contributor.authorHedley, D-
dc.contributor.authorChow, S-
dc.contributor.authorMoscow, J-
dc.contributor.authorPerry, M-
dc.contributor.authorDiaz-Padilla, I-
dc.contributor.authorTan, D-
dc.contributor.authorHirte, H-
dc.contributor.authorMcWhirter, E-
dc.contributor.authorChen, H-
dc.contributor.authorSiu, LL-
dc.contributor.authorBedard, PL-
dc.date.accessioned2016-10-14T13:48:38Z-
dc.date.available2016-10-14T13:48:38Z-
dc.date.issued2016-
dc.identifier.citationInvestigational New Drugs, 2016, v. 34 n. 1, p. 104-111-
dc.identifier.issn0167-6997-
dc.identifier.urihttp://hdl.handle.net/10722/234690-
dc.languageeng-
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997-
dc.relation.ispartofInvestigational New Drugs-
dc.rightsThe final publication is available at Springer via http://dx.doi.org/[insert DOI]-
dc.subjectAMG386-
dc.subjectCombination therapy-
dc.subjectPhase 1-
dc.subjectTemsirolimus-
dc.subjectTrebananib-
dc.titleA phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)-
dc.typeArticle-
dc.identifier.emailChiu, WYJ: jwychiu@hku.hk-
dc.identifier.authorityChiu, WYJ=rp01917-
dc.identifier.doi10.1007/s10637-015-0313-8-
dc.identifier.pmcidPMC4718956-
dc.identifier.scopuseid_2-s2.0-84959151856-
dc.identifier.hkuros267915-
dc.identifier.volume34-
dc.identifier.issue1-
dc.identifier.spage104-
dc.identifier.epage111-
dc.identifier.isiWOS:000368725100011-
dc.publisher.placeUnited States-
dc.identifier.issnl0167-6997-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats